Navigation Links
Thermage Reports Third Quarter Financial Results and Provides Information Regarding Reliant's Results
Date:11/10/2008

shares

outstanding used in

calculating non-GAAP

diluted net income (loss)

per share 24,905,958 23,913,461 24,918,711 23,737,094

Thermage, Inc.

CONDENSED BALANCE SHEETS

(in thousands of dollars, except share and per share data)

(Unaudited)

September 30, December 31,

2008 2007

ASSETS

Current assets:

Cash and cash equivalents $21,236 $13,650

Marketable investments 24,684 38,707

Accounts receivable, net 5,928 4,809

Inventories, net 6,823 6,639

Prepaid expenses and other current

assets 1,401 1,782

Total current assets 60,072 65,587

Property and equipment, net 3,132 3,000

Notes and interest receivable 5,164 -

Other assets 1,784 140

Total assets $70,152 $68,727

LIABILITIES AND STOCKHOLDERS' EQUITY

Liabilities:

Accounts payable $2,517 $1,341

Accrued liabilities 6,359 6,850

Current portion of deferred revenue 1,472 1,544

Customer deposits 57 18

Total current liabilities 10,405 9,753

Deferred revenue, net of current

portion
'/>"/>

SOURCE Thermage, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Thermage Discloses Preliminary 3Q 2008 Results for Thermage and Reliant
2. Thermage, Inc. to Present at the Maxim Group Growth Conference
3. Thermage Announces Second Quarter 2008 Financial Results
4. Thermage, Inc. to Present at the Fourth Annual Collins Stewart Growth Conference
5. Thermage and Reliant Technologies to Join Forces
6. Thermage, Inc. to Present at the Bank of America 2008 Healthcare Conference
7. Thermage, a Leading Aesthetic Medical Device Company, Announces First Time Exhibitor Status at ACOG Meeting
8. Thermage, Inc. Announces First Quarter 2008 Results Release Date and Conference Call
9. Thermage, Inc. Announces Initial Shipments of Cellulite Product
10. Thermage Announces Fourth Quarter and Full Year 2007 Financial Results
11. Thermage, Inc. Announces Fourth Quarter 2007 Results Release Date and Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:CareFusion Announces Six New Pyxis(R) Technologies at the ASHP Midyear Clinical Meeting and Exhibition 2CareFusion Announces Six New Pyxis(R) Technologies at the ASHP Midyear Clinical Meeting and Exhibition 3Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 2Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 3Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program 2Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program 3Schmidt 26 Clark LLP 3A FDA Reports Show Abbott Labs Subsidiary Failed to Disclose Parasite Eye Infections Tied to Contact Lens Solution 49653 1Schmidt 26 Clark LLP 3A FDA Reports Show Abbott Labs Subsidiary Failed to Disclose Parasite Eye Infections Tied to Contact Lens Solution 49653 2PhRMA Statement on AARP White House Press Conference 12729 1PhRMA Statement on AARP White House Press Conference 12729 2Public Ready for Changes to Health Care System But Unclear About Necessary Trade Offs Citizen Forums Suggest 49650 1Public Ready for Changes to Health Care System But Unclear About Necessary Trade Offs Citizen Forums Suggest 49650 2